Mycoplasma pneumoniae Detected In Seven Samples At AIIMS Delhi

AIIMS Delhi has identified Mycoplasma pneumoniae, implicated in the recent surge of pediatric respiratory illness in China, in seven samples from April to September. The Lancet Microbe reports one early-stage case via PCR testing and six later-stage cases through IgM Elisa testing, with respective positivity rates of 3% and 16%. Dr. Rama Chaudhry emphasizes M. pneumoniae causes 15-20% of community-acquired pneumonia, often mild or ‘walking pneumonia,’ but severe cases can occur. She advocates expanding surveillance in India, currently limited to AIIMS Delhi and a few centers.

Also Read: Income Tax Department Raids Odisha Alcohol Distillery, Seizes Rs. 50 Crore In Cash

The report underscores the need for global monitoring, with uncertain re-emergence severity and progression. Childhood pneumonia’s complexity involves various pathogens, immature immune systems, and risk factors. Preventive measures include immunization, improved nutrition, controlling indoor pollution, and prompt antibiotic treatment.

Also Read: PM Asserts: ‘I am Modi, Not Just a Distant Figure’ at BJP Parliamentary Gathering

In addressing the pneumonia outbreak in China, Dr. Sandeep Nayar advises precautions such as masks, social distancing, hand hygiene, and annual flu shots in India. Symptoms overlap with the flu, and the lifting of Covid restrictions in China may contribute to the outbreak. While not a cause for alarm in India, ongoing precautions are crucial. The government is actively taking preventive measures, particularly for vulnerable populations during winter. Continued diligence is vital to curb the spread of viral and bacterial infections.